ARCH Venture Management, LLC Diversified Active

CIK: 0001274403 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 12, 2019

Total Value ($000): $91,368 (100.0% shares, 0.0% debt)

Holdings (5)

— SYROS PHARMACEUTICALS INC 43.8%

Value ($000) $40,015 Shares 3,855,051 Est. Cost $10.38 Unrealized —

— RUBIUS THERAPEUTICS INC 22.5%

Value ($000) $20,554 Shares 2,618,351 Est. Cost $16.08 Unrealized —

KURA KURA ONCOLOGY INC 15.0%

Value ($000) $13,749 Shares 906,307 Est. Cost $13.25 Unrealized +34.4%

FATE FATE THERAPEUTICS INC 12.2%

Value ($000) $11,126 Shares 716,392 Est. Cost $13.94 Unrealized +37.5%

— CHIASMA INC 6.5%

Value ($000) $5,924 Shares 1,196,776 Est. Cost $3.11 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	SYROS PHARMACEUTICALS INC	3,855,051	$40,015	43.8%	$10.38	—	COM	87184Q107
—	RUBIUS THERAPEUTICS INC	2,618,351	$20,554	22.5%	$16.08	—	COM	78116T103
KURA	KURA ONCOLOGY INC	906,307	$13,749	15.0%	$13.25	+34.4%	COM	50127T109
FATE	FATE THERAPEUTICS INC	716,392	$11,126	12.2%	$13.94	+37.5%	COM	31189P102
—	CHIASMA INC	1,196,776	$5,924	6.5%	$3.11	—	COM	16706W102